An alternate network route
Some users of Endocrine-Related Cancer may find a consistency and reliability advantage in using a special private route to access the site. Endocrine-Related Cancer has made arrangements with a provider which offers an alternate network route through a global network serving 105 cities in 47 countries, encompassing the U.S., Canada, Latin America, Europe, the Middle East, Asia and the Pacific Rim. If you are experiencing trouble connecting to Endocrine-Related Cancer please try the alternate route instead to see if it provides you with better service.
To use the alternate route, go to http://intl-erc.endocrinology-journals.org
Most
-
Viewed
- Progesterone metabolites in breast cancer
- Association of Hashimoto's thyroiditis with thyroid cancer
- Lipomatous tumours in adrenal gland: WHO updates and clinical implications
- The emerging roles of DNA methylation in the clinical management of prostate cancer
- Reproductive disturbances in multiple neuroendocrine tumor syndromes
-
Cited
- Fibroblast growth factors, their receptors and signaling
- The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
- BRAF mutation in thyroid cancer
- mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
- Diabetes and cancer
